Literature DB >> 10559250

Actin and phosphoinositide binding by the ActA protein of the bacterial pathogen Listeria monocytogenes.

G Cicchetti1, P Maurer, P Wagener, C Kocks.   

Abstract

The surface protein ActA of the pathogenic bacterium Listeria monocytogenes induces actin-driven movement of bacteria in the cytoplasm of infected host cells and serves as a model for actin-based motility in general. We generated and purified soluble recombinant fragments of ActA and assessed their ability to interact with the acidic phospholipids phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate, both implicated in the regulation of actin polymerization. Purified ActA consisted of biologically active, elongated molecules with an alpha-helix and beta-sheet content of 11 and 32%, respectively. In the presence of either phosphatidylinositol 4,5-bisphosphate or phosphatidylinositol 3,4,5-trisphosphate, but not phosphatidylcholine, ActA molecules underwent a structural change that raised the alpha-helix content to 19% and lowered the beta-sheet content to 27%. Co-sedimentation experiments with phosphatidylcholine vesicles containing different acidic phospholipids demonstrated that ActA binds preferentially to D-3 phosphoinositides. The D-3 phosphoinositide binding activity was mapped to a small subregion in the N-terminal domain of ActA. This subregion comprised 19 amino acids and showed homology to cecropins. In addition, we found that amino acids 33 to 74 of ActA mediated actin binding by the whole, folded ActA molecule. These findings shed new light on ActA function.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10559250     DOI: 10.1074/jbc.274.47.33616

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

Review 1.  Actin-based motility of intracellular microbial pathogens.

Authors:  M B Goldberg
Journal:  Microbiol Mol Biol Rev       Date:  2001-12       Impact factor: 11.056

Review 2.  Molecular basis of the intracellular spreading of Shigella.

Authors:  T Suzuki; C Sasakawa
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

Review 3.  Quantifying lipid changes in various membrane compartments using lipid binding protein domains.

Authors:  Péter Várnai; Gergő Gulyás; Dániel J Tóth; Mira Sohn; Nivedita Sengupta; Tamas Balla
Journal:  Cell Calcium       Date:  2016-12-31       Impact factor: 6.817

4.  Growth of attached actin filaments.

Authors:  J Zhu; A E Carlsson
Journal:  Eur Phys J E Soft Matter       Date:  2006-11       Impact factor: 1.890

5.  Variations in the Nanomechanical Properties of Virulent and Avirulent Listeria monocytogenes.

Authors:  Bong-Jae Park; Nehal I Abu-Lail
Journal:  Soft Matter       Date:  2010-01-01       Impact factor: 3.679

Review 6.  Listeria pathogenesis and molecular virulence determinants.

Authors:  J A Vázquez-Boland; M Kuhn; P Berche; T Chakraborty; G Domínguez-Bernal; W Goebel; B González-Zorn; J Wehland; J Kreft
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

Review 7.  Polyphosphoinositide-Binding Domains: Insights from Peripheral Membrane and Lipid-Transfer Proteins.

Authors:  Joshua G Pemberton; Tamas Balla
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

Review 8.  There is more than one way to model an elephant. Experiment-driven modeling of the actin cytoskeleton.

Authors:  Jonathon A Ditlev; Bruce J Mayer; Leslie M Loew
Journal:  Biophys J       Date:  2013-02-05       Impact factor: 4.033

9.  How VASP enhances actin-based motility.

Authors:  Stanislav Samarin; Stephane Romero; Christine Kocks; Dominique Didry; Dominique Pantaloni; Marie-France Carlier
Journal:  J Cell Biol       Date:  2003-10-13       Impact factor: 10.539

10.  Adapter protein SH2-Bbeta stimulates actin-based motility of Listeria monocytogenes in a vasodilator-stimulated phosphoprotein (VASP)-dependent fashion.

Authors:  Maria Diakonova; Emmanuele Helfer; Stephanie Seveau; Joel A Swanson; Christine Kocks; Liangyou Rui; Marie-France Carlier; Christin Carter-Su
Journal:  Infect Immun       Date:  2007-04-23       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.